Evidence map›Paper›PMID 23001182›Full record

ArticleNature medicine2012

Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF-triggered granulopoiesis.

Julia Skokowa, Maxim Klimiankou, Olga Klimenkova, Dan Lan, Kshama Gupta, Kais Hussein, Esteban Carrizosa, Inna Kusnetsova, Zhixiong Li, Claudio Sustmann and 6 more

Open access · greenAbstract read
In one paragraph

Article in Nature medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 1 synthesis or guideline pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. HAX1 inhibits apoptosis and promotes maturation of neutrophils.Cell communication and signaling : CCS · 2025
    Article
  7. Flavopiridol restores granulopoiesis in experimental models of severe congenital neutropenia.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Emerging roles of MITF as a crucial regulator of immunity.Experimental & molecular medicine · 2024
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 3 countries.

Julia SkokowaDepartment of Molecular Hematopoiesis, Hannover Medical School, Hannover, Germany. skokowa.julia@mh-hannover.de
Maxim Klimiankou
Olga Klimenkova
Dan Lan
Kshama Gupta
Kais Hussein
Esteban Carrizosa
Inna Kusnetsova
Zhixiong Li
Claudio Sustmann
Arnold Ganser
Cornelia Zeidler
Hans-Heinrich Kreipe
Janis Burkhardt
Rudolf Grosschedl
Karl Welte
Medizinische Hochschule Hannover · DEMax Planck Institute of Immunobiology and Epigenetics · DEChildren's Hospital of Philadelphia · USUniversity of Pennsylvania · US

Funding

HS1 Function in Dendritic CellsR21AI088376 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI ARGON, YAIR, BURKHARDT, JANIS K. · 2010 to 2011
$458k
NIAID NIH HHS R21 AI088376
6 · The paper itself

Abstract

We found that hematopoietic cell-specific Lyn substrate 1 (HCLS1 or HS1) is highly expressed in human myeloid cells and that stimulation with granulocyte colony-stimulating factor (G-CSF) leads to HCLS1 phosphorylation. HCLS1 binds the transcription factor lymphoid-enhancer binding factor 1 (LEF-1), transporting LEF-1 into the nucleus upon G-CSF stimulation and inducing LEF-1 autoregulation. In patients with severe congenital neutropenia, inherited mutations in the gene encoding HCLS1-associated protein X-1 (HAX1) lead to profound defects in G-CSF-triggered phosphorylation of HCLS1 and subsequently to reduced autoregulation and expression of LEF-1. Consistent with these results, HCLS1-deficient mice are neutropenic. In bone marrow biopsies of the majority of tested patients with acute myeloid leukemia, HCLS1 protein expression is substantially elevated, associated with high levels of G-CSF synthesis and, in some individuals, a four-residue insertion in a proline-rich region of HCLS1 protein known to accelerate intracellular signaling. These data demonstrate the importance of HCLS1 in myelopoiesis in vitro and in vivo.

Indexed as

MyelopoiesisActive Transport, Cell NucleusAdaptor Proteins, Signal TransducingAnimalsBase SequenceBlood ProteinsCell LineCell ProliferationCongenital Bone Marrow Failure SyndromesFemaleGranulocyte Colony-Stimulating FactorGranulocytesHEK293 CellsHumansLeukemia, Myeloid, AcuteLymphoid Enhancer-Binding Factor 1Adaptor Proteins, Signal TransducingBlood ProteinsGranulocyte Colony-Stimulating FactorHAX1 protein, humanHCLS1 protein, humanLEF1 protein, humanLymphoid Enhancer-Binding Factor 1Receptors, Granulocyte Colony-Stimulating FactorRNA, Small Interfering

Identifiers

PMID23001182
PMCPMC3941918
OpenAlexW2158571482

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.